{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:43Z","timestamp":1740136363663,"version":"3.37.3"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10072-020-04779-7","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T21:03:14Z","timestamp":1601413394000},"page":"1197-1198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to \u201cAxonal\u201d form of Guillain-Barr\u00e9 syndrome in a patient receiving oxaliplatin-based chemotherapy"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7283-8687","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maelle","family":"Tyberghein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"4779_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00415-019-09614-4","volume":"267","author":"T Gr\u00fcter","year":"2020","unstructured":"Gr\u00fcter T, Ott A, Meyer W, Jarius S, Kinner M, Motte J, Pitarokoili K, Gold R, Komorowski L, Ayzenberg I (2020) Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity. J Neurol 267:715\u2013720","journal-title":"J Neurol"},{"key":"4779_CR2","doi-asserted-by":"publisher","unstructured":"Jia L, Zhang H (2020) Axonal form of Guillain-Barr\u00e9 syndrome in a patient receiving oxaliplatin-based chemotherapy. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04560-w","DOI":"10.1007\/s10072-020-04560-w"},{"key":"4779_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1212\/01.WNL.0000133205.05169.04","volume":"63","author":"S Kuwabara","year":"2004","unstructured":"Kuwabara S, Ogawara K, Misawa S, Koga M, Mori M, Hiraga A, Kanesaka T, Hattori T, Yuki N (2004) Does Campylobacter jejuni infection elicit \u201cdemyelinating\u201d Guillain-Barre syndrome? Neurology 63:529\u2013533","journal-title":"Neurology"},{"key":"4779_CR4","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10072-019-04199-2","volume":"41","author":"M Tyberghein","year":"2020","unstructured":"Tyberghein M, Milants C, Bouquiaux O, Wang F (2020) Axonal form of Guillain-Barr\u00e9 syndrome in a patient receiving oxaliplatin-based chemotherapy. Neurol Sci 41:1611\u20131613. https:\/\/doi.org\/10.1007\/s10072-019-04199-2","journal-title":"Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04779-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04779-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04779-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:43:18Z","timestamp":1632876198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04779-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4779"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04779-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"27 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the participant included in the paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}